I’m not saying I am happy. I wish this thing would go straight up on YOY growth and a strong balance sheet but that is not this company...right now. I also wish previous deadlines were met and objectives reached. But I’ve learned over the past year that deadlines don’t seem to get met (2 divs, uplist, spinout) LOIs don’t necessarily lead to closing deals (Kiromic), that there are people out there that don’t want GNBT to succeed (CMF, Veneto, shorts) and like I said I will adjust my investment strategy accordingly.
I’ll give you another old saying. Fool me once shame on you, fool me twice shame on me. Reality is the position we are in is not (all) Joes fault. I’ve had 2 opportunities in a year to get out with a nice profit. During that same time frame I held GILD. A Multi billion dollar giant with tons of cash on hand that pays a cash dividend every quarter, has multiple approved drugs. Know how many times I could have gotten out of that with a profit...ZERO
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links